The Innovation Exchange
Applications for the 2026 Innovation Exchange have now closed.
This September, six of Europe's most promising early-stage advanced therapy companies will take to the main stage to present their science, strategy and commercial vision to an audience of investors, pharma leaders and industry decision-makers. Join us in Barcelona to watch the finalists pitch live.
Innovation Exchange Partner:
The Innovation Exchange is Advanced Therapies Europe's flagship biotech pitch competition, designed to showcase emerging therapeutic developers with breakthrough science and strong commercial potential.
Embedded within the main conference programme, the session brings together founders, investors, pharma executives and strategic partners for an afternoon of live pitches, investor questioning and high-value discussion.
Launched in 2025, the Innovation Exchange has quickly become one of the week's standout sessions, shining a spotlight on the companies shaping the future of advanced therapies.
What you'll see live:
Our judging panel brings together leading investors, biotech executives and strategic partners who will evaluate each company live, ask the questions that matter, and select the recipient of the 2026 Innovation Exchange Award.
Venture Associate at UCB Ventures
Rahul invests in innovative biotechnology companies at UCB Ventures, supporting investments in breakthrough therapeutics with expertise spanning life sciences, strategy, venture capital and healthcare finance.
Analyst at Ysios Capital
Malgorzata combines a distinguished scientific background in molecular biology with venture investing at Ysios Capital, identifying and supporting the next generation of life sciences innovators.
Investor at Delin Ventures
Matt invests in cell therapy companies and enabling technologies at Delin Ventures, combining experience in venture capital, corporate strategy and biotech operations to support emerging innovators.
Kindling Bio captured the inaugural Innovation Exchange Award in 2025, impressing the judging panel with its scientific innovation, commercial vision and potential to transform patient outcomes.
Read how their Innovation Exchange experience helped elevate their profile and what's happened since taking the stage.
Read the article
See who's already in the room this September
Explore the organisations already registered for Advanced Therapies Europe 2026, from therapeutic developers and pharma to investors, CDMOs, regulators and solution providers.
Download the 2026 Attendee List so far
)
)
)
)
)
)
)
)
)
)
